维普期刊资源整合服务平台（V6.5）

77篇 您的检索式：作者名="WESSELY R"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhibition of neointima formation by a novel drugeluting stent system that allows for doseadjustable, multiple, and on-site stent coating显示文摘	WESSELY R HAUSLEITER J MICHAELIS C	2005	Arterioscler Thromb Vasc Biol2005，251，：	1
2	The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim 1/Lhxl 显示文摘	Agrawal R Tran U Wessely O	2009	Development2009，136，23：	1
3	Choice of contrast medium inpatients with impaired renal function undergoing pereutaneous coronary intervention显示文摘	Wessely R Koppara T Bradaric C	2009	Circ Cardiovasc Interv2009，2，：	1
4	MicroRNAs in kidney development:Lessons from the frog显示文摘	Wessely O Agrawal R Tran U		0，，：	1
5	The miR-30 miRNA family regulates xenopus pronephros development and targets the transcription factor Xlim1/Lhx1显示文摘	Agrawal R Tran U Wessely O		0，，23：	1
6	Cardiac involvement in Emery-Dreifuss muscular dystrophy显示文摘	Wessely R Seidl S Schomig A	2005	Clin Genet2005，67，：	1
7	The assessment of fatigue : a practical guide for clinicians and researchers 显示文摘	Dittner A J Wessely S C Brown R G	2004	J Psychosom Res2004，56，2：	1
8	Active placebos versus antidepressants for depression显示文摘	Moncrieff J Wessely S Hardy R	2004	Cochrane Database Syst Rev2004，，00：	1
9	Active placebos versus antidepressants for depression显示文摘	Moncrieff J Wessely S Hardy R	2004	Cochrane Database Syst Rev2004，，00：	1
10	Cardioselective infection with coxsackievirus B3 requires intact type Ⅰ interferon signaling:implications for mortality and early viral replication显示文摘	Wessely R Klinge I K Knowlton K U	2001	Circulation2001，103，5：	1
11	Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy显示文摘	Wessely R Klingel K Santana LF	1998	J Clin Invest1998，102，7：	1
12	Investment in Technological Innovations:An Option Pricing Approach显示文摘	Grenadier S R Wess A	1997	Journal of Financial Economics1997，，：	1
13	Inhibition of neointima formation by a novel drugeluting stent system that allows for dose adjustable, multiple, and on-site stent coating显示文摘	WESSELY R HAUSLEITER J MICHAELIS C	2005	Arterioscler Thromb Vasc Biol2005，25，：	1
14	Randomized trial of rapamycin- and paclitaxel-eluting stents with identical bio- degradable polymeric coating and design显示文摘	Wessely R Kastrati A Mehilli J	2007	European Heart Journal2007，28，22：	1
15	Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention显示文摘	Wessely R Koppara T Bradaric C	2009	Circ Cardiovasc Interv2009，2，5：	1
16	Evaluation and management of renal injuries: consensus statement of the renal trauma subcommittee显示文摘	Santucci R A Wesselis H	2004	BJU International2004，93，7：	1
17	Prevention of restenosis by a novel drug-eluting stent system with a doseadjustable,polymerfree,on-site stent coating显示文摘	Kastrati A Wessely R	2005	Eur Heart J2005，26，12：	1
18	Biochemical analysis of collagen in clubfeet and in controls显示文摘	Krauspe R Wess KM Raab P		0，，：	1
19	Interference by interferons: Janus faces in vascular proliferative diseases显示文摘	Wessely R	2005	Cardiovasc Res2005，66，3：	1
20	Sirolimus and Paclitaxel on polymer-based drug-eluting stents:similar but different 显示文摘	Wessely R Sehomig A Kastrati A	2006	J Am Coll Cardiol2006，47，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示